Exploring the Potential of Direct-To-Consumer Genomic Test Data for Predicting Adverse Drug Events

Recent technological advancements in genetic testing and the growing accessibility of public genomic data provide researchers with a unique avenue to approach personalized medicine. This feasibility study examined the potential of direct-to-consumer (DTC) genomic tests (focusing on 23andMe) in resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Patrick M., Sarkar, Indra Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Informatics Association 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961769/
https://www.ncbi.nlm.nih.gov/pubmed/29888082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961769/
https://www.ncbi.nlm.nih.gov/pubmed/29888082

Ejemplares similares